EIPG Newsletter

Spain: An Office to support innovation and knowledge of medicinal products

The Spanish regulatory agency AEMPS has established an Office to support innovation and knowledge of medicinal products, to help independent researchers and small companies to develop their products

EMA’s and FDA’s 2018 Work Plans

The two regulatory agencies EMA and FDA published their 2018 Work Plans: many new activities will modernise the approval reference framework on the two side of the Atlantic Ocean

The increasing role of China in the scientific and pharmaceutical sectors

China has become a true scientific leader in life sciences, with many clinical trials going on with innovative medicines. The Asiatic giant also overcame the US as per number of scientific articles published in 2016 and ranks at the second place for investments in R&D

An update on orphan medicines and rare diseases

Orphan medicines and rare diseases are an area of great investments by pharmaceutical companies, as they can benefit of a 10 years market exclusivity. Rules to obtain orphan designation and regulatory procedures differs between Europe and the US

EIPG’s March roundup

During the last month EIPG's representatives participated to the General Assembly of VAPI UPIP and to the EPSA General Reception. A new joint statement on medicine shortages and more.

EIPG meets the Order des Pharmaciens

During the last month EIPG's representatives met the the French Ordre des Pharmaciens. Updates also from the Bureau Meeting and on the National Medicines Verification Organisation

UK: An app to measure glucose without the need of blood samples

Just place a fingertip over the camera lens of the smartphone to read glycemic levels in blood: it's the promise of a new app developed in UK by Epic Health

Exome sequencing of genetic data to speed up R&D

A new pre-competitive consortium led by Regeneron will fund the exome sequencing of the biological samples obtained from the half million volunteers adhering to the UK Biobank

ICMRA: towards global standards for track-and-trace systems

The International Coalition of Medicines Regulatory Authorities (ICMRA) adopted new Recommendations to align track and trace (T&T) systems at the international level in order to reach interoperability

What is going on in neurosciences?

Research in Alzheimer's and Parkinson's diseases is suffering a difficult moment due to the many failures in clinical trials. While Pfizer and Merck leaved the challenge, Bill Gates invested $ 50 million in the Dementia Discovery Fund